|
|
central nervous system development
|
GO:0007417 |
387 |
0.943
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.923
|
|
|
|
eye development
|
GO:0001654 |
277 |
0.864
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.853
|
|
|
|
stem cell development
|
GO:0048864 |
82 |
0.836
|
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.824
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.756
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.746
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.717
|
|
|
|
eye morphogenesis
|
GO:0048592 |
144 |
0.700
|
|
|
|
camera type eye morphogenesis
|
GO:0048593 |
108 |
0.699
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.674
|
|
|
|
appendage development
|
GO:0048736 |
80 |
0.672
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.667
|
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.605
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
1 |
0.586
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
79 |
0.584
|
|
|
|
pectoral fin development
|
GO:0033339 |
50 |
0.576
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.568
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.563
|
|
|
|
fin development
|
GO:0033333 |
77 |
0.559
|
|
|
|
ear development
|
GO:0043583 |
127 |
0.557
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.557
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.525
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.522
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.521
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
42 |
0.510
|
|
|
|
response to lipid
|
GO:0033993 |
60 |
0.505
|
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.482
|
|
|
|
camera type eye development
|
GO:0043010 |
222 |
0.475
|
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.466
|
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.454
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.434
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
48 |
0.428
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.415
|
|
|
|
midbrain development
|
GO:0030901 |
28 |
0.401
|
|
|
|
positive regulation of metabolic process
|
GO:0009893 |
108 |
0.393
|
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.390
|
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.388
|
|
|
|
cell migration involved in heart development
|
GO:0060973 |
22 |
0.381
|
|
|
|
vasculogenesis
|
GO:0001570 |
41 |
0.365
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
79 |
0.361
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
2 |
0.357
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.356
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
57 |
0.355
|
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.353
|
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.349
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.341
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.331
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
12 |
0.330
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.313
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.311
|
|
|
|
inner ear receptor cell development
|
GO:0060119 |
20 |
0.307
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.299
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.293
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.282
|
|
|
|
glial cell migration
|
GO:0008347 |
3 |
0.279
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
195 |
0.278
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.277
|
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.276
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.275
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
98 |
0.274
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.259
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.259
|
|
|
|
otic placode formation
|
GO:0043049 |
23 |
0.258
|
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.251
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
39 |
0.244
|
|
|
|
glial cell differentiation
|
GO:0010001 |
42 |
0.243
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.243
|
|
|
|
somite development
|
GO:0061053 |
96 |
0.242
|
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.237
|
|
|
|
tissue regeneration
|
GO:0042246 |
74 |
0.234
|
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.232
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
59 |
0.224
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
63 |
0.223
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.222
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
11 |
0.221
|
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.220
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.220
|
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.219
|
|
|
|
heart jogging
|
GO:0003146 |
40 |
0.218
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
48 |
0.214
|
|
|
|
cellular response to fatty acid
|
GO:0071398 |
3 |
0.212
|
|
|
|
cellular response to organic substance
|
GO:0071310 |
105 |
0.211
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
56 |
0.209
|
|
|
|
otic vesicle development
|
GO:0071599 |
42 |
0.208
|
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
3 |
0.207
|
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.204
|
|
|
|
brain development
|
GO:0007420 |
293 |
0.202
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.201
|
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.193
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
1 |
0.192
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
2 |
0.192
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
29 |
0.191
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.188
|
|
|
|
response to growth factor
|
GO:0070848 |
39 |
0.180
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.173
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.173
|
|
|
|
negative regulation of mitosis
|
GO:0045839 |
3 |
0.173
|
|
|
|
response to estrogen
|
GO:0043627 |
27 |
0.171
|
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
32 |
0.170
|
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.170
|
|
|
|
heart looping
|
GO:0001947 |
94 |
0.168
|
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.167
|
|
|
|
head development
|
GO:0060322 |
303 |
0.166
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.163
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
1 |
0.163
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.161
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.161
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
1 |
0.160
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.159
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
30 |
0.157
|
|
|
|
cell fate specification
|
GO:0001708 |
68 |
0.156
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.156
|
|
|
|
liver development
|
GO:0001889 |
96 |
0.152
|
|
|
|
cell proliferation
|
GO:0008283 |
80 |
0.152
|
|
|
|
negative regulation of axonogenesis
|
GO:0050771 |
7 |
0.151
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.150
|
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.149
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
55 |
0.146
|
|
|
|
embryonic pattern specification
|
GO:0009880 |
44 |
0.146
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
2 |
0.144
|
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.144
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.142
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.140
|
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.140
|
|
|
|
cell fate commitment
|
GO:0045165 |
99 |
0.140
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.140
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
204 |
0.139
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
1 |
0.136
|
|
|
|
gliogenesis
|
GO:0042063 |
45 |
0.136
|
|
|
|
kupffer s vesicle development
|
GO:0070121 |
50 |
0.136
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.134
|
|
|
|
palate development
|
GO:0060021 |
8 |
0.133
|
|
|
|
positive regulation of muscle organ development
|
GO:0048636 |
1 |
0.133
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
2 |
0.132
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.132
|
|
|
|
pronephros development
|
GO:0048793 |
69 |
0.130
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.130
|
|
|
|
otolith development
|
GO:0048840 |
32 |
0.129
|
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.127
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.126
|
|
|
|
epithelial cell migration
|
GO:0010631 |
25 |
0.126
|
|
|
|
lateral line system development
|
GO:0048925 |
76 |
0.124
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
68 |
0.124
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
231 |
0.124
|
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.122
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.121
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
27 |
0.119
|
|
|
|
ear morphogenesis
|
GO:0042471 |
64 |
0.118
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
59 |
0.118
|
|
|
|
heart valve development
|
GO:0003170 |
14 |
0.116
|
|
|
|
response to hormone
|
GO:0009725 |
48 |
0.116
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.115
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
20 |
0.115
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.114
|
|
|
|
neuron development
|
GO:0048666 |
262 |
0.114
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.113
|
|
|
|
aging
|
GO:0007568 |
2 |
0.112
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.111
|
|
|
|
cranial nerve development
|
GO:0021545 |
42 |
0.111
|
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.111
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.108
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
78 |
0.108
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.107
|
|
|
|
skin development
|
GO:0043588 |
54 |
0.104
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.102
|
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.100
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.100
|
|
|
|
response to ketone
|
GO:1901654 |
1 |
0.099
|
|
|
|
gastrulation
|
GO:0007369 |
208 |
0.098
|
|
|
|
regulation of cell migration
|
GO:0030334 |
40 |
0.096
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
74 |
0.096
|
|
|
|
renal system development
|
GO:0072001 |
94 |
0.096
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
8 |
0.095
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.095
|
|
|
|
dendrite development
|
GO:0016358 |
9 |
0.095
|
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.095
|
|
|
|
fin morphogenesis
|
GO:0033334 |
53 |
0.094
|
|
|
|
regulation of dna replication
|
GO:0006275 |
3 |
0.093
|
|
|
|
urogenital system development
|
GO:0001655 |
97 |
0.092
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
4 |
0.092
|
|
|
|
regulation of cell motility
|
GO:2000145 |
46 |
0.089
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
58 |
0.089
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.089
|
|
|
|
cellular protein modification process
|
GO:0006464 |
100 |
0.088
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.088
|
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.088
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
244 |
0.086
|
|
|
|
axial mesoderm development
|
GO:0048318 |
10 |
0.086
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
45 |
0.086
|
|
|
|
growth
|
GO:0040007 |
174 |
0.084
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
2 |
0.083
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
68 |
0.083
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
2 |
0.081
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
20 |
0.081
|
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
45 |
0.080
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
0 |
0.079
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.079
|
|
|
|
somatic muscle development
|
GO:0007525 |
4 |
0.078
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
1 |
0.078
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
87 |
0.078
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.078
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
1 |
0.077
|
|
|
|
negative regulation of tor signaling
|
GO:0032007 |
2 |
0.077
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.076
|
|
|
|
protein localization
|
GO:0008104 |
40 |
0.075
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
72 |
0.074
|
|
|
|
pectoral fin morphogenesis
|
GO:0035138 |
29 |
0.073
|
|
|
|
central nervous system myelination
|
GO:0022010 |
2 |
0.073
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.073
|
|
|
|
neuron differentiation
|
GO:0030182 |
353 |
0.072
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
15 |
0.072
|
|
|
|
venous endothelial cell migration involved in lymph vessel development
|
GO:0060855 |
4 |
0.071
|
|
|
|
cell death
|
GO:0008219 |
121 |
0.069
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
143 |
0.069
|
|
|
|
kidney development
|
GO:0001822 |
92 |
0.069
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
22 |
0.068
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.068
|
|
|
|
cell adhesion
|
GO:0007155 |
40 |
0.067
|
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.067
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.066
|
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.066
|
|
|
|
neural crest cell migration
|
GO:0001755 |
42 |
0.066
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.066
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
20 |
0.066
|
|
|
|
endothelium development
|
GO:0003158 |
25 |
0.065
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.065
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
1 |
0.065
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.064
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.064
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
2 |
0.062
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
2 |
0.062
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.062
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.062
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.061
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
52 |
0.061
|
|
|
|
axon extension
|
GO:0048675 |
45 |
0.060
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
3 |
0.060
|
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.059
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
20 |
0.059
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.058
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.058
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
52 |
0.058
|
|
|
|
gland development
|
GO:0048732 |
143 |
0.058
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
1 |
0.057
|
|
|
|
specification of organ identity
|
GO:0010092 |
2 |
0.057
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.057
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.056
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
68 |
0.056
|
|
|
|
cell migration
|
GO:0016477 |
237 |
0.056
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.055
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
52 |
0.055
|
|
|
|
death
|
GO:0016265 |
121 |
0.055
|
|
|
|
regulation of axonogenesis
|
GO:0050770 |
32 |
0.055
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
85 |
0.055
|
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.054
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
96 |
0.054
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
18 |
0.054
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
20 |
0.054
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
0 |
0.053
|
|
|
|
axon development
|
GO:0061564 |
166 |
0.053
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
26 |
0.053
|
|
|
|
lymph vessel development
|
GO:0001945 |
27 |
0.053
|
|
|
|
regulation of heart growth
|
GO:0060420 |
2 |
0.053
|
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.053
|
|
|
|
response to inorganic substance
|
GO:0010035 |
38 |
0.053
|
|
|
|
regeneration
|
GO:0031099 |
91 |
0.053
|
|
|
|
phosphorus metabolic process
|
GO:0006793 |
109 |
0.052
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.052
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.052
|
|
|
|
mesoderm formation
|
GO:0001707 |
43 |
0.052
|
|
|
|
organ formation
|
GO:0048645 |
17 |
0.051
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.051
|
|
|
|
ectodermal placode development
|
GO:0071696 |
37 |
0.051
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.051
|
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.051
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.051
|
|
|
|
optic nerve development
|
GO:0021554 |
15 |
0.051
|
|
|
|
neural crest cell development
|
GO:0014032 |
62 |
0.051
|
|
|
|
protein polymerization
|
GO:0051258 |
4 |
0.051
|
|
|
|
heart process
|
GO:0003015 |
71 |
0.051
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.050
|
|
|
|
heart field specification
|
GO:0003128 |
1 |
0.049
|
|
|
|
notochord cell differentiation
|
GO:0060034 |
18 |
0.049
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.049
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
15 |
0.049
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
13 |
0.049
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
0 |
0.049
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
3 |
0.049
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.048
|
|
|
|
otic vesicle morphogenesis
|
GO:0071600 |
34 |
0.048
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
23 |
0.048
|
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
104 |
0.048
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
116 |
0.047
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
163 |
0.047
|
|
|
|
nerve development
|
GO:0021675 |
45 |
0.047
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
1 |
0.047
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.047
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
11 |
0.047
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.045
|
|
|
|
biological adhesion
|
GO:0022610 |
40 |
0.045
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.045
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
56 |
0.045
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
87 |
0.045
|
|
|
|
neural tube development
|
GO:0021915 |
62 |
0.045
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.045
|
|
|
|
stem cell division
|
GO:0017145 |
1 |
0.044
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
45 |
0.044
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
11 |
0.044
|
|
|
|
epidermis development
|
GO:0008544 |
48 |
0.044
|
|
|
|
otic vesicle formation
|
GO:0030916 |
27 |
0.043
|
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.043
|
|
|
|
chemosensory behavior
|
GO:0007635 |
1 |
0.043
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
7 |
0.043
|
|
|
|
axonogenesis
|
GO:0007409 |
152 |
0.042
|
|
|
|
pharynx development
|
GO:0060465 |
5 |
0.042
|
|
|
|
endocrine system development
|
GO:0035270 |
65 |
0.042
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.041
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
71 |
0.041
|
|
|
|
endothelial cell migration
|
GO:0043542 |
19 |
0.041
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.040
|
|
|
|
establishment or maintenance of monopolar cell polarity
|
GO:0061339 |
2 |
0.040
|
|
|
|
myelination
|
GO:0042552 |
18 |
0.039
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
1 |
0.039
|
|
|
|
system process
|
GO:0003008 |
185 |
0.039
|
|
|
|
locomotion
|
GO:0040011 |
313 |
0.039
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
55 |
0.039
|
|
|
|
macromolecule modification
|
GO:0043412 |
111 |
0.039
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
52 |
0.039
|
|
|
|
heart contraction
|
GO:0060047 |
71 |
0.038
|
|
|
|
muscle cell fate determination
|
GO:0007521 |
1 |
0.038
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
7 |
0.038
|
|
|
|
cell cycle
|
GO:0007049 |
93 |
0.038
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.038
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.037
|
|
|
|
regulation of protein binding
|
GO:0043393 |
3 |
0.037
|
|
|
|
tissue migration
|
GO:0090130 |
37 |
0.036
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
9 |
0.036
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
11 |
0.036
|
|
|
|
cranial suture morphogenesis
|
GO:0060363 |
1 |
0.036
|
|
|
|
axis specification
|
GO:0009798 |
43 |
0.036
|
|
|
|
fin regeneration
|
GO:0031101 |
51 |
0.035
|
|
|
|
tube formation
|
GO:0035148 |
25 |
0.035
|
|
|
|
sex determination
|
GO:0007530 |
1 |
0.035
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
3 |
0.035
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
38 |
0.035
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.035
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
15 |
0.035
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.035
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
1 |
0.034
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
22 |
0.034
|
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.034
|
|
|
|
diencephalon development
|
GO:0021536 |
58 |
0.034
|
|
|
|
cellular monovalent inorganic cation homeostasis
|
GO:0030004 |
2 |
0.034
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
4 |
0.034
|
|
|
|
axon ensheathment
|
GO:0008366 |
18 |
0.033
|
|
|
|
lateral line development
|
GO:0048882 |
66 |
0.033
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
64 |
0.033
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
3 |
0.033
|
|
|
|
cellular component disassembly
|
GO:0022411 |
1 |
0.033
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.033
|
|
|
|
3 utr mediated mrna stabilization
|
GO:0070935 |
3 |
0.032
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.032
|
|
|
|
regulation of locomotion
|
GO:0040012 |
55 |
0.032
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.032
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
2 |
0.032
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
0 |
0.031
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
4 |
0.031
|
|
|
|
cellular protein metabolic process
|
GO:0044267 |
129 |
0.031
|
|
|
|
limb development
|
GO:0060173 |
8 |
0.031
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
2 |
0.031
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
13 |
0.031
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
56 |
0.031
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.031
|
|
|
|
positive regulation of cellular metabolic process
|
GO:0031325 |
94 |
0.030
|
|
|
|
inner ear receptor cell fate commitment
|
GO:0060120 |
4 |
0.030
|
|
|
|
tube closure
|
GO:0060606 |
1 |
0.030
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
23 |
0.030
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
1 |
0.030
|
|
|
|
retinal cone cell development
|
GO:0046549 |
8 |
0.030
|
|
|
|
pancreas development
|
GO:0031016 |
84 |
0.030
|
|
|
|
gtp metabolic process
|
GO:0046039 |
4 |
0.030
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.030
|
|
|
|
cardiac cell development
|
GO:0055006 |
21 |
0.030
|
|
|
|
endocytosis
|
GO:0006897 |
16 |
0.030
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
1 |
0.030
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
3 |
0.029
|
|
|
|
embryonic pectoral fin morphogenesis
|
GO:0035118 |
24 |
0.029
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
2 |
0.029
|
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.029
|
|
|
|
notch signaling pathway
|
GO:0007219 |
35 |
0.029
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
21 |
0.029
|
|
|
|
gene expression
|
GO:0010467 |
252 |
0.029
|
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.029
|
|
|
|
regulation of filopodium assembly
|
GO:0051489 |
2 |
0.028
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
4 |
0.028
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
4 |
0.028
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
2 |
0.028
|
|
|
|
cellular response to stress
|
GO:0033554 |
62 |
0.028
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
93 |
0.028
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
94 |
0.028
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
51 |
0.027
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
2 |
0.027
|
|
|
|
protein import into nucleus
|
GO:0006606 |
3 |
0.027
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
3 |
0.027
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
37 |
0.027
|
|
|
|
negative regulation of endodermal cell differentiation
|
GO:1903225 |
8 |
0.027
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
57 |
0.027
|
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.027
|
|
|
|
axon ensheathment in central nervous system
|
GO:0032291 |
2 |
0.027
|
|
|
|
response to cadmium ion
|
GO:0046686 |
14 |
0.027
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
161 |
0.027
|
|
|
|
hindbrain development
|
GO:0030902 |
91 |
0.027
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
12 |
0.026
|
|
|
|
negative regulation of axon extension involved in axon guidance
|
GO:0048843 |
1 |
0.026
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
14 |
0.026
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
56 |
0.026
|
|
|
|
artery morphogenesis
|
GO:0048844 |
14 |
0.026
|
|
|
|
pigmentation
|
GO:0043473 |
85 |
0.026
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.026
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.025
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
4 |
0.025
|
|
|
|
paraxial mesoderm development
|
GO:0048339 |
8 |
0.025
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
6 |
0.025
|
|
|
|
epithelial cell development
|
GO:0002064 |
42 |
0.024
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
3 |
0.024
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
13 |
0.024
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
3 |
0.024
|
|
|
|
establishment of epithelial cell polarity
|
GO:0090162 |
2 |
0.024
|
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.024
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
86 |
0.024
|
|
|
|
nephric duct development
|
GO:0072176 |
13 |
0.024
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
2 |
0.024
|
|
|
|
wound healing
|
GO:0042060 |
90 |
0.024
|
|
|
|
establishment of apical basal cell polarity
|
GO:0035089 |
2 |
0.024
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.024
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
14 |
0.024
|
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.024
|
|
|
|
heart valve formation
|
GO:0003188 |
4 |
0.024
|
|
|
|
atrioventricular canal development
|
GO:0036302 |
5 |
0.024
|
|
|
|
adherens junction organization
|
GO:0034332 |
4 |
0.024
|
|
|
|
epithelial cell proliferation involved in liver morphogenesis
|
GO:0072575 |
2 |
0.023
|
|
|
|
hepatocyte proliferation
|
GO:0072574 |
2 |
0.023
|
|
|
|
transport
|
GO:0006810 |
220 |
0.023
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
1 |
0.023
|
|
|
|
regulation of cell fate specification
|
GO:0042659 |
20 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
104 |
0.023
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
1 |
0.023
|
|
|
|
establishment of epithelial cell apical basal polarity
|
GO:0045198 |
2 |
0.023
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
16 |
0.023
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
57 |
0.023
|
|
|
|
sympathetic ganglion development
|
GO:0061549 |
2 |
0.023
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
1 |
0.023
|
|
|
|
response to wounding
|
GO:0009611 |
116 |
0.023
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
30 |
0.023
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
21 |
0.023
|
|
|
|
regulation of cell shape
|
GO:0008360 |
1 |
0.023
|
|
|
|
extracellular structure organization
|
GO:0043062 |
27 |
0.023
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.022
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.022
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.022
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
29 |
0.022
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
3 |
0.022
|
|
|
|
negative regulation of anterior neural cell fate commitment of the neural plate
|
GO:0022001 |
1 |
0.022
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
139 |
0.022
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
3 |
0.022
|
|
|
|
mesoderm development
|
GO:0007498 |
88 |
0.022
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
1 |
0.021
|
|
|
|
regulation of cell proliferation involved in heart morphogenesis
|
GO:2000136 |
2 |
0.021
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.021
|
|
|
|
limb morphogenesis
|
GO:0035108 |
7 |
0.021
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
16 |
0.021
|
|
|
|
immune system development
|
GO:0002520 |
191 |
0.021
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
96 |
0.021
|
|
|
|
primary neural tube formation
|
GO:0014020 |
1 |
0.021
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
2 |
0.021
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.021
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.021
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
37 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
15 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
1 |
0.020
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
55 |
0.020
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
18 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
22 |
0.020
|
|
|
|
neuronal action potential
|
GO:0019228 |
18 |
0.020
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
43 |
0.020
|
|
|
|
regulation of cardiac muscle cell differentiation
|
GO:2000725 |
1 |
0.020
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
80 |
0.020
|
|
